InvestorsHub Logo
Followers 20
Posts 1059
Boards Moderated 0
Alias Born 04/01/2013

Re: IgnoranceIsBliss post# 216968

Monday, 09/30/2019 1:01:57 PM

Monday, September 30, 2019 1:01:57 PM

Post# of 425649
I don't know, if you don't have an ownership position in AMRN by now, especially after all the shares available at the raise, why would you buy now and not wait to have it de-risked? Without some positive news not a lot of catalyst to buy, the sector is out of favor right now so program trading would be short.

I'm not sure BP has all this stuff to fear. Like what do they stand to lose? Statins are still going to be needed, the alternatives and add-ons are not big percent of any BP sales. When label expanded they could buy Amarin and then leverage pricing and other areas and get a positive return out of it, if it gets denied what value is it to BP?

Supplement manufacturers, maybe more to lose, but if it's approved how much more valuable are the words "epa"? It could help there sales dramatically, only negative is if Amarin somehow prevents them from selling EPA as a supplement but that's unlikely.

I think it's more market sector sentiment, hangover from large dilution and lack of news than the work of BP or Supplements as I don't see they have all that much to lose by Amarin approval.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News